Search research articles
Contact Us
Filters
Showing results (111-120 of 163) with videos related to
Page
of 17
Sort By:
Genomics
|
June 1, 2020
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment
Jinhui Liu, Sipei Nie, Zhipeng Wu, et al.
Cell Death & Disease
|
December 8, 2025
IL7R remodels immunosuppression tumor microenvironment and promotes macrophage polarization by regulating NF-κB/CXCL1 axis in ovarian cancer
Yeqing Zheng, Cheng Qian, Shuyi Zhang, et al.
Cancer Cell International
|
February 27, 2020
Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study
JinHui Liu, Mingming Feng, SiYue Li, et al.
Oncotargets and Therapy
|
December 11, 2019
Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6
Mi Gong, Chengyan Luo, Huangyang Meng, et al.
Journal of Ovarian Research
|
September 3, 2021
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
Sipei Nie, Yicong Wan, Hui Wang, et al.
Scientific Reports
|
October 22, 2024
Effectiveness and biocompatibility of a novel Schlemm's canal microstent for glaucoma management
Manman Huang, Yu Zhang, Zhao Chen, et al.
Zhonghua Fu Chan Ke Za Zhi
|
October 21, 2014
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study]
Yi Fu, Weifeng Mi, Lingzhi Li, et al.
Science Advances
|
April 15, 2026
Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity
Huangyang Meng, Qianjing Chang, Yashuang Zhang, et al.
International Journal of Biological Sciences
|
September 9, 2024
Olaparib combined with CDK12-IN-3 to promote genomic instability and cell death in ovarian cancer
Jianqiang Liang, Xuan Zhou, Lin Yuan, et al.
Japanese Journal of Radiology
|
September 10, 2024
Multi-modality MRI radiomics phenotypes in intermediate-high risk endometrial cancer: correlations with histopathology and prognosis
Jiacheng Song, Xiaoting Jiang, Yao Lu, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 163) with videos related to
Sort By:
Page
of 17
Genomics
|
June 1, 2020
Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment
Jinhui Liu, Sipei Nie, Zhipeng Wu, et al.
Cell Death & Disease
|
December 8, 2025
IL7R remodels immunosuppression tumor microenvironment and promotes macrophage polarization by regulating NF-κB/CXCL1 axis in ovarian cancer
Yeqing Zheng, Cheng Qian, Shuyi Zhang, et al.
Cancer Cell International
|
February 27, 2020
Identification of molecular markers associated with the progression and prognosis of endometrial cancer: a bioinformatic study
JinHui Liu, Mingming Feng, SiYue Li, et al.
Oncotargets and Therapy
|
December 11, 2019
Upregulated LINC00565 Accelerates Ovarian Cancer Progression By Targeting GAS6
Mi Gong, Chengyan Luo, Huangyang Meng, et al.
Journal of Ovarian Research
|
September 3, 2021
CXCL2-mediated ATR/CHK1 signaling pathway and platinum resistance in epithelial ovarian cancer
Sipei Nie, Yicong Wan, Hui Wang, et al.
Scientific Reports
|
October 22, 2024
Effectiveness and biocompatibility of a novel Schlemm's canal microstent for glaucoma management
Manman Huang, Yu Zhang, Zhao Chen, et al.
Zhonghua Fu Chan Ke Za Zhi
|
October 21, 2014
[Efficacy and safety of a combined oral contraceptive containing drospirenone 3 mg and ethinylestradiol 20 µg in the treatment of premenstrual dysphoric disorder: a randomized, double blind placebo-controlled study]
Yi Fu, Weifeng Mi, Lingzhi Li, et al.
Science Advances
|
April 15, 2026
Multiomics profiling and experiments in preclinical models revealed RAD51-IN-1 as a synergistic potentiator of anlotinib sensitivity
Huangyang Meng, Qianjing Chang, Yashuang Zhang, et al.
International Journal of Biological Sciences
|
September 9, 2024
Olaparib combined with CDK12-IN-3 to promote genomic instability and cell death in ovarian cancer
Jianqiang Liang, Xuan Zhou, Lin Yuan, et al.
Japanese Journal of Radiology
|
September 10, 2024
Multi-modality MRI radiomics phenotypes in intermediate-high risk endometrial cancer: correlations with histopathology and prognosis
Jiacheng Song, Xiaoting Jiang, Yao Lu, et al.
Page
of 17